Commentary
See article on page 473Boning up on vitamin K
| The first 150 words of the full text of this article appear below. |
The nature and significance of the relationship between vitamin
K status and bone health has been debated for some years. Vitamin K is
required for the gamma carboxylation of glutamic acid residues in three
bone proteins, namely osteocalcin, matrix Gla protein, and protein S. Although the roles of these proteins have not been clearly defined,
there is evidence that osteocalcin, which is produced by cells of the
osteocyte/osteoblast lineage and has three vitamin K dependent gamma
carboxyglutamic acid (Gla) residues, may be involved in the
mineralisation of bone matrix1; in addition, it may
function as a negative regulator of bone formation, deletion of the
osteocalcin gene in mice resulting in increased bone
mass.2 Approximately 30% of synthesised osteocalcin is released into the circulation and serum levels of the protein are
widely used as an indicator of bone formation.3 Vitamin K
deficiency is associated with a reduction in circulating osteocalcin concentrations
Relevant Article
- Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?
- E J Schoon, M C A Müller, C Vermeer, L J Schurgers, R-J M Brummer, and R W Stockbrügger
Gut 2001 48: 473-477.[Abstract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
